期刊文献+

卡维地洛和美托洛尔治疗高血压的疗效及其对糖脂代谢影响比较 被引量:1

下载PDF
导出
摘要 目的比较卡维地洛和美托洛尔的应用治疗高血压的治疗效果及其对血糖与血脂的代谢影响。方法选取我院收治的玉级、域级原发性高血压患者80例做为研究对象。随机分为观察组(卡维地洛组)与对照组(美托洛尔组),每组40例。治疗10 w后,比较两组患者治疗前后血压、血脂与空腹血糖等临床指标。结果观察组患者的治疗总有效率显著高于对照组,差异具统计学意义(<0.05)。治疗后两组患者的降压效果无显著差异,不具统计学意义(跃0.05)。观察组患者的空腹血LDC原C、Chol等临床数据优于对照组,糖、差异具统计学意义(<0.05)。结论应用卡维地洛可以有效降低高血压患者的血压,还具有降血糖、降血脂的作用,促进糖脂代谢,值得临床推广应用。
作者 吴航
机构地区 青海省中医院
出处 《医学信息(医学与计算机应用)》 2014年第15期205-205,共1页 Medical Information
  • 相关文献

参考文献4

二级参考文献34

  • 1Frohlich E D.Role of beta-adrenergic receptor blocking agentsin hypertensive diseases:personal thoughts as the controversypersists[J].Ther Adv Cardiovasc Dis,2009,3(6):455.
  • 2Bakris G L,Bell D S,Fonseca V,et al.The rationale and de-sign of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives(GEMINI)trial[J].J Diabetes Complications,2005,19(2):74.
  • 3Richardson P,Mckenna W,Bristow M. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies[J].Circulation,1996,(05):841-842.
  • 4Cleland JG,Bristow MR,Erdmann E. Beta-blocking agents in heart failure.Should they be used and how[J].European Heart Journal,1996,(11):1629-1639.
  • 5Singh M,Roginskaya M,Dalal S. Extracellular ubiquitin inhibits beta-AR-stimulated apoptosis in cardiac myocytes:role of GSK-3beta and mitochondrial pathways[J].Cardiovascular Research,2010,(01):20-28.
  • 6Zhao FP,Guo Z,Wang PF. Calcitonin gene related peptide(CGRP) inhibits norepinephrine induced apoptosis in cultured rat cardiomyocytes not via PKA or PKC pathways[J].Neuroscience Letters,2010,(02):163-166.
  • 7Metra M,Covolo L,Pezzali N. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure[J].Cardiovascular Drugs and Therapy,2010,(01):49-60.
  • 8Solomon SD,Shin SH,Shah A. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction[J].European Heart Journal,2011,(10):1227-1234.
  • 9Metra M,Nodari S,Bordonali T. Beta-blocker therapy of heart failure:an update[J].Expert Opinion on Pharmacotherapy,2007,(03):289-298.doi:10.1517/14656566.8.3.289.
  • 10Kober L,Torp-Pedersen C,Carlsen JE. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction.Trandolapril Cardiac Evaluation (TRACE) Study Group[J].New England Journal of Medicine,1995,(25):1670-1676.

共引文献53

同被引文献44

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部